Skip to main content
. 2023 Sep 5;12(18):5783. doi: 10.3390/jcm12185783

Table 3.

Clinical outcomes and ICU complications.

All
N = 1090
COPD
N = 88
Non-COPD
N = 1002
p-Value
28-day mortality, n (%) 319 (29%) 36 (41%) 283 (28%) 0.02
90-day mortality, n (%) 369 (34%) 39 (44%) 330 (33%) 0.04
In-hospital mortality, n (%) 364 (37%) 39 (49%) 325 (36%) 0.02
ICU mortality, n (%) 354 (33%) 38 (45%) 316 (32%) 0.02
Length of hospital stay, days, median [IQR] 23 [14–37] 20 [11–31] 24 [14–37] 0.06
Length of ICU stay, days, median [IQR] 15 [9–26] 12 [8–24] 16 [9–26] 0.11
Ventilator-free days at day 28, days, median [IQR] 16 [10–28] 14 [10–30] 16 [10–28] 0.92
Duration of ventilation, days, median [IQR] 14 [8–23] 11 [8–20] 14 [8–23] 0.07
Tracheostomy, n (%) 187 (17%) 14 (16%) 173 (17%) 0.76
Pneumothorax, n (%) 41 (4%) 4 (5%) 37 (4%) 0.57
Thromboembolic complications, n (%)
Pulmonary embolism 244 (22%) 20 (23%) 224 (22%) 0.94
Deep vein thrombosis 53 (5%) 5 (6%) 48 (5%) 0.61
Ischemic stroke 31 (3%) 3 (3%) 28 (3%) 0.73
Myocardial infarction 16 (1%) 0 (0%) 16 (2%) 0.63
Systemic arterial thrombosis 4 (0%) 1 (1%) 3 (0%) 0.29
Acute kidney injury, n (%) 488 (45%) 38 (43%) 450 (45%) 0.73
Re-intubation, n (%) 138 (13%) 8 (9%) 130 (13%) 0.30

Abbreviations: COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; IQR, interquartile range.